Skip to main content
Oncotarget logoLink to Oncotarget
. 2025 Dec 31;16:865. doi: 10.18632/oncotarget.28792

Retraction: Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells

Matthew L Fisher 1, Daniel Grun 1, Gautam Adhikary 1, Wen Xu 1, Richard L Eckert 1,2,3,4,
PMCID: PMC12776643

The initial request from the authors was for a correction, citing a mistaken placement of images and providing original blots. However, the Scientific Integrity Office conducted an independent verification of the results and discovered additional instances of image manipulation:

  1. Duplication of Western blots in Figure 4G and 4H (b-actin in A375-PLX-R cells).

  2. Reuse of the YAP-1 blot from Figure 1F in Figure 3A, illustrating a different experiment.

In light of the number of necessary corrections and in agreement with the recommendations from the ORI (NIH), the Editorial decision has been made to retract this paper.

Original article: Oncotarget. 2017; 8:110257–110272. 110257-110272. https://doi.org/10.18632/oncotarget.22628


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES